Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |